Has Layron Long, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,628 in general payments to Layron Long, MD across 93 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Layron Long, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Layron Long, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Layron Long, MD

Urology · Corvallis, ORNPI 1649382417

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,678 of the $14,628 with a category attached, or 73.0%. Ambu A/s accounts for 66.8% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2023 at $10,870 and has fallen 84.4% since, to $1,697 in 2025. Among urology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,628in general payments, 2019–2025

Across 93 payments — averaging $157.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ambu A/s$10K
Intuitive Surgical$1K
Ambu Inc.$1K
Boston Scientific$594
Lazarus 3d$573
AbbVie$298
plus $1K from 23 others

What the payments were for

Consulting fees$10,67873%
Speaking & faculty fees$1,0007%
Food & beverage$2,87220%
Education$280%
Gifts$500%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ambu A/s	1	$9,778
Intuitive Surgical	7	$1,196
Ambu Inc.	3	$1,049
Boston Scientific	13	$594
Lazarus 3d	4	$573
AbbVie(2 entities)	14	$298
Laborie Medical Technologies Corp.	4	$132
Urogen Pharma, Inc.	4	$123
Procept Biorobotics Corporation	2	$106
Accord Healthcare, Inc.	4	$95
Merck	4	$85
Conmed Corporation	3	$83
Myriad Genetic Laboratories, Inc.	4	$61
Pfizer	3	$61
Sumitomo Pharma America, Inc.	3	$60
Tolmar, Inc.	2	$47
Johnson & Johnson(2 entities)	2	$46
Endo Pharmaceuticals Inc.	2	$33
Astellas Pharma US Inc	2	$30
Medtronic	1	$26
Angiodynamics, Inc.	1	$22
Baxter Healthcare	1	$22
Edwards Lifesciences	1	$20
Bayer	1	$19
Photocure Inc	1	$18
Verity Pharmaceuticals Inc.	1	$15
Axonics, Inc.	1	$14
KARL Storz Endoscopy-america	1	$13
Travere Therapeutics, Inc.	3	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,628 in reported general payments places this provider in the 90th percentile of 153 urology providers in Oregon.

See all urology providers in Oregon →

Medicare billing

Part B allowed, 2024

$98,518

Medicare patients

270

Services billed

632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	142	$2,918
Finasteride	18	$414
Oxybutynin Chloride	26	$214
Cephalexin	13	$168
Ciprofloxacin Hcl	67	$135
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	18	$109
Tramadol Hcl	94	$105
Tobramycin Sulfate	12	$90
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	19	$68
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	11	$26

Paid to pharmacies, not to this prescriber.

Other urology in Corvallis

Robert LaciakCorvallis$17K
Bryce AllioCorvallis$5K
Kadi Ann BryanCorvallis$4K
Bryan MehlhaffSpringfield$1M
Lance MarrPortland$323K
Matt AshleyBend$212K
da David JiangPortland$65K
Kim ThaiMedford$57K
Kevin KrughoffSpringfield$54K
Kyle GillisClackamas$51K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →